A milder clinical course for severe hemophilia B: a true or biased effect?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Managing Relevant Clinical Conditions of Hemophilia A/B Patients.Hematology reports · 2023
   Article
2. Recent Advances in the Treatment of Hemophilia: A Review.Biologics : targets & therapy · 2021
   Review
3. A contribution to the debate about the possible different clinical severity between hemophilia A and B.Haematologica · 2016
   Article
4. Differences in Major Bleeding Events Between Patients With Severe Hemophilia A and Hemophilia B: A Nationwide, Population-Based Cohort Study.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
   Article

Corrections and comments

• Commented on by
  A contribution to the debate about the possible different clinical severity between hemophilia A and B.2016
• Comment on
  Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A.2016

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as